Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEADFAST: Telaprevir and Sofosbuvir in HCV Genotype 1
NCT01994486Phase 2Completed
- Sponsor
- University of Florida
- Start
- Dec 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of telaprevir in hepatitis C (HCV), sponsored by University of Florida. Started Dec 2013; status: completed.
02
Drugs
telaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01994486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01994486.